Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Digestive System Neoplasms 3Digestive System Diseases 3Neoplasms, Glandular and Epithelial 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2Carcinoma 2Uterine Cervical Dysplasia 1Urogenital Neoplasms 1Stomach Neoplasms 1Stomach Diseases 1Rectal Diseases 1Pancreatic Neoplasms 1Pancreatic Diseases 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms 1Neoplasm Metastasis 1Intestinal Neoplasms 1Intestinal Diseases 1Head and Neck Neoplasms 1Gonadal Disorders 1Genital Neoplasms, Female 1Genital Diseases, Female 1Female Urogenital Diseases and Pregnancy Complications 1Female Urogenital Diseases 1Esophageal Neoplasms 1Esophageal Diseases 1Colorectal Neoplasms 1

Interventions

Papillomavirus Vaccines 2Imiquimod 2GX-188 vaccine 2Celecoxib 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2poly(gamma-glutamic acid) 1pembrolizumab 1nimotuzumab 1epigallocatechin gallate 1artesunic acid 1artemisinin 1Sutures 1Progesterone 1Pemetrexed 1Omeprazole 1Ointments 1Ocoxin 1Nelfinavir 1Lighting 1Indomethacin 1IRX 2 1Hepatitis B Vaccines 1Geritol 1GPI0100 1Folic Acid 1Eflornithine 1Cyclophosphamide 1Conization 1Cisplatin 1Chemoprevention 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Uterine Cervical Dysplasia × Ocoxin × Clear all
NCT03549273 2024-02-07

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

Catalysis SL

Phase 2 Unknown
62 enrolled
Gynecologic

Carcinoma, Uterine Cervical Dysplasia, Neoplasms, Neoplasms, Glandular and Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡